Integration of B-Type Natriuretic Peptide Levels With Clinical Data and Exercise Testing for Predicting Coronary Artery Disease

American Journal of Cardiology

Volumn 98, Issue 6, 2006, Pages 764-767

  Wolber, Thomas ^a   Maeder, Micha ^b   Weilenmann, Daniel ^b   Duru, Firat ^a   Bluzaite, Ina ^b   Riesen, Walter ^c   Rickli, Hans ^b   Ammann, Peter ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Division of Cardiology   (Switzerland)

^c Institute for Clinical Chemistry and Hematology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EXERCISE TEST; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STABLE ANGINA PECTORIS; SYSTOLE; VALVULAR HEART DISEASE;

ADULT; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33748050123     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.063     Document Type: Article

References (17)

1. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 suppl 6A (2004) 9S-16S
2. de Lemos J.A., and Morrow D.A. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. Rev Cardiovasc Med 4 suppl 4 (2003) S37-S46
3. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
4. de Bold A.J., Ma K.K., Zhang Y., de Bold M.L., Bensimon M., and Khoshbaten A. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 79 (2001) 705-714
5. Foote R.S., Pearlman J.D., Siegel A.H., and Yeo K.T. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
6. Struthers A.D., and Davies J. B-type natriuretic peptide: a simple new test to identify coronary artery disease?. Quart J Med 98 (2005) 765-769
7. Weber M., Dill T., Arnold R., Rau M., Ekinci O., Muller K.D., Berkovitsch A., Mitrovic V., and Hamm C. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
8. Ndrepepa G., Braun S., Mehilli J., von Beckerath N., Vogt W., Schomig A., and Kastrati A. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. Am J Cardiol 95 (2005) 553-557
9. Schnabel R., Rupprecht H.J., Lackner K.J., Lubos E., Bickel C., Meyer J., Munzel T., Cambien F., Tiret L., and Blankenberg S. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 26 (2005) 241-249
10. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
11. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., Ebrahim S., Faergeman O., Graham I., Mancia G., et al., Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24 (2003) 1601-1610
12. Fischer Y., Filzmaier K., Stiegler H., Graf J., Fuhs S., Franke A., Janssens U., and Gressner A.M. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 47 (2001) 591-594
13. Clerico A., Prontera C., Emdin M., Passino C., Storti S., Poletti R., Zyw L., and Zucchelli G.C. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP. Clin Chem 51 (2005) 445-447
14. Mackinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 30 (2000) 127-134
15. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease?. Data from the Heart and Soul Study. Am J Med 116 (2004) 509-516
16. Asada J., Tsuji H., Iwasaka T., Thomas J.D., and Lauer M.S. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 93 (2004) 702-704
17. Palumbo B., Siepi D., Lupattelli G., Sinzinger H., Fiorucci G., Anniboletti P.F., Latini R.A., Mannarino E., and Palumbo R. Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol 94 (2004) 780-783